Back to search

Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir

Data up to Jan 2025

Published2004
Citations95
References26

Total Citations Per Year

Abstract

References (26)

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

1998 • 9,382 citations

Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

2000 • 3,295 citations

A systematic review of the associations between dose regimens and medication compliance

2001 • 2,366 citations

Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability

1989 • 2,127 citations

Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals

1995 • 1,370 citations

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

2000 • 1,050 citations

Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy

1998 • 861 citations

Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection Duration

1998 • 751 citations

Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy

2000 • 708 citations

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

2002 • 647 citations

Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

2001 • 566 citations

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

1999 • 548 citations

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

1997 • 423 citations

Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

2001 • 382 citations

Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral Therapy

1999 • 256 citations

Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical Practice

2001 • 220 citations

3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine

2000 • 205 citations

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

2002 • 166 citations

Adherence to Triple Therapy and Viral Load Response

2000 • 116 citations

Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection

1999 • 80 citations

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)

2001 • 62 citations

Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy

2002 • 42 citations

Clinical Pharmacology and Pharmacokinetics of Amprenavir

2002 • 37 citations

Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy

2000 • 30 citations

Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy

2000 • 29 citations

A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience

1999 • 28 citations

Cited By (0)

Loading...
Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the… (2004) – Antimicrobial Agents and Chemotherapy | Metascience Observatory Explorer